Traumatic spinal cord injury

Nature Reviews Disease Primers

Volumn 3, Issue , 2017, Pages

  Ahuja, Christopher S ^a   Wilson, Jefferson R ^a   Nori, Satoshi ^b   Kotter, Mark R N ^c   Druschel, Claudia ^d   Curt, Armin ^e,f   Fehlings, Michael G ^a,g  

^a UNIVERSITY OF TORONTO   (Canada)

^b KEIO UNIVERSITY   (Japan)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

^f UNIVERSITY OF ZURICH   (Switzerland)

^g TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE SODIUM SUCCINATE; MYELIN; GLUCOCORTICOID; METHYLPREDNISOLONE;

AGING; APOPTOSIS; AUTONOMIC DYSREFLEXIA; CALCIUM CELL LEVEL; CELL DEATH; CELL PERMEABILIZATION; CELL REGENERATION; CLINICAL OUTCOME; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DECUBITUS; GLIA; HEMODYNAMIC MONITORING; HETEROTOPIC OSSIFICATION; HOSPITAL CARE; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; INFLAMMATORY CELL; INTENSIVE CARE UNIT; MEDICAL HISTORY; MICROGLIA; MORTALITY; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SHOCK; SPASTICITY; SPINAL CORD DECOMPRESSION; SPINAL CORD INJURY; SYRINGOMYELIA; TRAFFIC ACCIDENT; X RAY; ANATOMY AND HISTOLOGY; COMPLICATION; ELECTROTHERAPY; HYPOTENSION; INJURY; INNERVATION; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE; RADIOGRAPHY; SPINE; X-RAY COMPUTED TOMOGRAPHY;

ELECTRIC STIMULATION THERAPY; GLUCOCORTICOIDS; HUMANS; HYPOTENSION; MAGNETIC RESONANCE IMAGING; METHYLPREDNISOLONE; QUALITY OF LIFE; RADIOGRAPHY; SPINAL CORD INJURIES; SPINE; SYRINGOMYELIA; TOMOGRAPHY, X-RAY COMPUTED; WOUNDS AND INJURIES;

EID: 85018891841     PISSN: None     EISSN: 2056676X     Source Type: Journal    
DOI: 10.1038/nrdp.2017.18     Document Type: Review

References (222)

1. Noonan, V. K., Dvorak, M. F. & Fehlings, M. G. in Critical Care in Spinal Cord Injury (ed. Fehlings, M. G.) 6-20 (Future Medicine Ltd, 2013).
2. [No authors listed.] Spinal cord injury facts and figures at a glance. J. Spinal Cord Med. 37, 117-118 (2014).
3. Singh, A., Tetreault, L., Kalsi-Ryan, S., Nouri, A. & Fehlings, M. G. Global prevalence and incidence of traumatic spinal cord injury. Clin. Epidemiol. 6, 309-331 (2014).
4. Cripps, R. A. et al. A global map for traumatic spinal cord injury epidemiology: towards a living data repository for injury prevention. Spinal Cord 49, 493-501 (2011).
5. Noonan, V. K. et al. Incidence and prevalence of spinal cord injury in Canada: a national perspective. Neuroepidemiology 38, 219-226 (2012).
6. New, P. W., Farry, A., Baxter, D. & Noonan, V. K. Prevalence of non-traumatic spinal cord injury in Victoria, Australia. Spinal Cord 51, 99-102 (2013).
7. Chen, Y., He, Y. & DeVivo, M. J. Changing demographics and injury profile of new traumatic spinal cord injuries in the United States, 1972-2014. Arch. Phys. Med. Rehabil. 97, 1610-1619 (2016).
8. van den Berg, M. E., Castellote, J. M., Mahillo-Fernandez, I. & de Pedro-Cuesta, J. Incidence of spinal cord injury worldwide: a systematic review. Neuroepidemiology 34, 184-192 (2010).
9. Lenehan, B. et al. The epidemiology of traumatic spinal cord injury in British Columbia, Canada. Spine 37, 321-329 (2012).
10. Devivo, M. J. Epidemiology of traumatic spinal cord injury: trends and future implications. Spinal Cord 50, 365-372 (2012).
11. DeVivo, M. J. & Chen, Y. Trends in new injuries, prevalent cases, and aging with spinal cord injury. Arch. Phys. Med. Rehabil. 92, 332-338 (2011).
12. Wu, J. C. et al. Effects of age, gender, and socio-economic status on the incidence of spinal cord injury: an assessment using the eleven-year comprehensive nationwide database of Taiwan. J. Neurotrauma 29, 889-897 (2012).
13. Wu, J. C. et al. Epidemiology of cervical spondylotic myelopathy and its risk of causing spinal cord injury: a national cohort study. Neurosurg. Focus 35, E10 (2013).
14. Krause, J., Sternberb, M., Lottes, S. & Maides, J. Mortality after spinal cord injury: an 11-year prospective study. Arch. Phys. Med. Rehabil. 78, 815-821 (1997).
15. LaPlaca, M. C., Simon, C. M., Prado, G. R. & Cullen, D. K. CNS injury biomechanics and experimental models. Prog. Brain Res. 161, 13-26 (2007).
16. Choo, A. M. et al. Contusion, dislocation, and distraction: primary hemorrhage and membrane permeability in distinct mechanisms of spinal cord injury. J. Neurosurg. Spine 6, 255-266 (2007).
17. Pineau, I. & Lacroix, S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J. Comp. Neurol. 500, 267-285 (2007).
18. Schanne, F. A., Kane, A. B., Young, E. E. & Farber, J. L. Calcium dependence of toxic cell death: a final common pathway. Science 206, 700-702 (1979).
19. Kwon, B. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J. 4, 451-464 (2004).
20. Dizdaroglu, M., Jaruga, P., Birincioglu, M. & Rodriguez, H. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic. Biol. Med. 32, 1102-1115 (2002).
21. Hausmann, O. N. Post-traumatic inflammation following spinal cord injury. Spinal Cord 41, 369-378 (2003).
22. Liu, M. et al. Necroptosis, a novel type of programmed cell death, contributes to early neural cells damage after spinal cord injury in adult mice. J. Spinal Cord Med. 38, 745-753 (2015).
23. Wang, Y. et al. Necroptosis inhibitor necrostatin-1 promotes cell protection and physiological function in traumatic spinal cord injury. Neuroscience 266, 91-101 (2014).
24. Li, S., Mealing, G. A., Morley, P. & Stys, P. K. Novel injury mechanism in anoxia and trauma of spinal cord white matter: glutamate release via reverse Na+-dependent glutamate transport. J. Neurosci. 19, RC16 (1999).
25. Li, S. & Stys, P. K. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J. Neurosci. 20, 1190-1198 (2000).
26. Norenberg, M. D., Smith, J. & Marcillo, A. The pathology of human spinal cord injury: defining the problems. J. Neurotrauma 21, 429-440 (2004).
27. Tator, C. H. Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathol. 5, 407-413 (1995).
28. Milhorat, T. H., Capocelli, A. L., Anzil, A. P., Kotzen, R. M. & Milhorat, R. H. Pathological basis of spinal cord cavitation in syringomyelia: analysis of 105 autopsy cases. J. Neurosurg. 82, 802-812 (1995).
29. McKeon, R. J., Schreiber, R. C., Rudge, J. S. & Silver, J. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J. Neurosci. 11, 3398-3411 (1991).
30. Ahuja, C. S., Martin, A. R. & Fehlings, M. Recent advances in managing a spinal cord injury secondary to trauma. F1000Res. 5 (F1000 Faculty Rev), 1017 (2016).
31. Cregg, J. M. et al. Functional regeneration beyond the glial scar. Exp. Neurol. 253, 197-207 (2014).
32. Silver, J. & Miller, J. H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5, 146-156 (2004).
33. Wanner, I. B. et al. Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J. Neurosci. 33, 12870-12886 (2013).
34. Anderson, M. A. et al. Astrocyte scar formation aids central nervous system axon regeneration. Nature 532, 195-200 (2016).
35. Rolls, A., Shechter, R. & Schwartz, M. The bright side of the glial scar in CNS repair. Nat. Rev. Neurosci. 10, 235-241 (2009).
36. Filbin, M. T. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat. Rev. Neurosci. 4, 703-713 (2003).
37. Forgione, N. & Fehlings, M. G. Rho-ROCK inhibition in the treatment of spinal cord injury. World Neurosurg. 82, e535-e539 (2014).
38. Lee, J. K. et al. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice. Neuron 66, 663-670 (2010).
39. Geoffroy, C. G. & Zheng, B. Myelin-associated inhibitors in axonal growth after CNS injury. Curr. Opin. Neurobiol. 27, 31-38 (2014).
40. Fehlings, M. G. & Tator, C. H. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp. Neurol. 132, 220-228 (1995).
41. Tator, C. H. & Fehlings, M. G. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75, 15-26 (1991).
42. Kotter, M. R., Li, W. W., Zhao, C. & Franklin, R. J. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J. Neurosci. 26, 328-332 (2006).
43. Syed, Y. A. et al. Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination. Acta Neuropathol. 131, 281-298 (2016).
44. Kotter, M. R., Setzu, A., Sim, F. J., Van Rooijen, N. & Franklin, R. J. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 35, 204-212 (2001).
45. Bieber, A. J., Warrington, A., Pease, L. R. & Rodriguez, M. Humoral autoimmunity as a mediator of CNS repair. Trends Neurosci. 24, S39-S44 (2001).
46. Jeffery, N. D. & Blakemore, W. F. Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous remyelination. Brain 120, 27-37 (1997).
47. Lynskey, J. V., Belanger, A. & Jung, R. Activity-dependent plasticity in spinal cord injury. J. Rehabil. Res. Dev. 45, 229-240 (2008).
48. Raineteau, O. & Schwab, M. E. Plasticity of motor systems after incomplete spinal cord injury. Nat. Rev. Neurosci. 2, 263-273 (2001).
49. Meletis, K. et al. Spinal cord injury reveals multilineage differentiation of ependymal cells. PLoS Biol. 6, e182 (2008).
50. Barnabe-Heider, F. et al. Origin of new glial cells in intact and injured adult spinal cord. Cell Stem Cell 7, 470-482 (2010).
51. Mao, Y., Nguyen, T., Sutherland, T. & Gorrie, C. A. Endogenous neural progenitor cells in the repair of the injured spinal cord. Neural Regen. Res. 11, 1075-1076 (2016).
52. Bradbury, E. J. et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416, 636-640 (2002).
53. Li, G. et al. Mdivi-1 inhibits astrocyte activation and astroglial scar formation and enhances axonal regeneration after spinal cord injury in rats. Front. Cell. Neurosci. 10, 241 (2016).
54. Tator, C. H. Review of treatment trials in human spinal cord injury. Neurosurgery 59, 957-987 (2006).
55. Zhang, N., Fang, M., Chen, H., Gou, F. & Ding, M. Evaluation of spinal cord injury animal models. Neural Regen. Res. 9, 2008-2012 (2014).
56. Nout, Y. S. et al. Animal models of neurologic disorders: a nonhuman primate model of spinal cord injury. Neurotherapeutics 9, 380-392 (2012).
57. Kwon, B. K. et al. Large animal and primate models of spinal cord injury for the testing of novel therapies. Exp. Neurol. 269, 154-168 (2015).
58. Fisher, M. et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40, 2244-2250 (2009).
59. Tator, C. H. Acute spinal cord injury: a review of recent studies of treatment and pathophysiology. Can. Med. Assoc. J. 107, 143-145 (1972).
60. Wilson, J. R., Forgione, N. & Fehlings, M. G. Emerging therapies for acute traumatic spinal cord injury. CMAJ 185, 485-492 (2013).
61. Guha, A., Tator, C. H. & Rochon, J. Spinal cord blood flow and systemic blood pressure after experimental spinal cord injury in rats. Stroke 20, 372-377 (1989).
62. Guha, A. B. & Tator, C. H. Acute cardiovascular effects of experimental spinal cord injury. J. Trauma 28, 481-490 (1988).
63. Schwab, J. M., Zhang, Y., Kopp, M. A., Brommer, B. & Popovich, P. G. The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury. Exp. Neurol. 258, 121-129 (2014).
64. Ko, H., Dittuno, J., Graziani, V. & Little, J. The pattern of reflex recovery during spinal shock. Spinal Cord 37, 402-409 (1999).
65. Ploumis, A., Yadlapalli, N., Fehlings, M. G., Kwon, B. K. & Vaccaro, A. R. A systematic review of the evidence supporting a role for vasopressor support in acute SCI. Spinal Cord 48, 356-362 (2010).
66. Lehmann, K. G., Lane, J. G., Piepmeier, J. M. & Batsford, W. P. Cardiovascular abnormalities accompanying acute spinal cord injury in humans: incidence, time course and severity. J. Am. Coll. Cardiol. 10, 46-52 (1987).
67. Guly, H. R., Bouamra, O., Lecky, F. E. & Trauma Audit and Research Network. The incidence of neurogenic shock in patients with isolated spinal cord injury in the emergency department. Resuscitation 76, 57-62 (2008).
68. Acheson, M., Livingston, R., Richardson, M. & Stimac, G. High-resolution CT scanning in the evaluation of cervical spine fractures: comparison with plain film examinations. AJR Am. J. Roentgenol. 148, 1179-1185 (1987).
69. Woodring, J. & Lee, C. Limitations of cervical radiography in the evaluation of acute cervical trauma. J. Trauma 34, 32-39 (1993).
70. Vaccaro, A. R. et al. AOSpine subaxial cervical spine injury classification system. Eur. Spine J. 25, 2173-2184 (2016).
71. Vaccaro, A. R. et al. AOSpine thoracolumbar spine injury classification system: fracture description, neurological status, and key modifiers. Spine 38, 2028-2037 (2013).
72. Lammertse, D. et al. Neuroimaging in traumatic spinal cord injury: an evidence-based review for clinical practice and research. J. Spinal Cord Med. 30, 205-214 (2007).
73. Miyanji, F., Furlan, J., Aarabi, B., Arnold, P. & Fehlings, M. Acute cervical traumatic spinal cord injury: MR imaging findings correlated with neurologic outcome - prospective study with 100 consecutive patients. Radiology 243, 820-827 (2007).
74. Vaccaro, A. R. et al. Magnetic resonance evaluation of the intervertebral disc, spinal ligaments, and spinal cord before and after closed traction reduction of cervical spine dislocations. Spine 24, 1210-1217 (1999).
75. Nakashima, H. et al. Posterior approach for cervical fracture-dislocations with traumatic disc herniation. Eur. Spine J. 20, 387-394 (2011).
76. Resnick, D. K. Updated guidelines for the management of acute cervical spine and spinal cord injury. Neurosurgery 72 (Suppl. 3), 1 (2013).
77. Cadotte, D. W. & Fehlings, M. G. Will imaging biomarkers transform spinal cord injury trials Lancet Neurol. 12, 843-844 (2013).
78. Curt, A. & Dietz, V. Electrophysiological recordings in patients with spinal cord injury: significance for predicting outcome. Spinal Cord 37, 157-165 (1999).
79. Curt, A., Van Hedel, H. J., Klaus, D., Dietz, V. & Group, E.-S. S. Recovery from a spinal cord injury: significance of compensation, neural plasticity, and repair. J. Neurotrauma 25, 677-685 (2008).
80. Kirshblum, S. C. et al. Reference for the 2011 revision of the International Standards for Neurological Classification of Spinal Cord Injury. J. Spinal Cord Med. 34, 547-554 (2011).
81. American Spinal Injury Association. ISNCSCI worksheet. ASIA http://asia-spinalinjury.org/information/downloads/ (2000).
82. Marino, R. J., Jones, L., Kirshblum, S., Tal, J. & Dasgupta, A. Reliability and repeatability of the motor and sensory examination of the international standards for neurological classification of spinal cord injury. J. Spinal Cord Med. 31, 166-170 (2008).
83. Savic, G., Bergstrom, E. M., Frankel, H. L., Jamous, M. A. & Jones, P. W. Inter-rater reliability of motor and sensory examinations performed according to American Spinal Injury Association standards. Spinal Cord 45, 444-451 (2007).
84. Sherwood, A. M., Dimitrijevic, M. R. & McKay, W. B. Evidence of subclinical brain influence in clinically complete spinal cord injury: discomplete SCI. J. Neurol. Sci. 110, 90-98 (1992).
85. Schneider, R. C., Cherry, G. & Pantek, H. The syndrome of acute central cervical spinal cord injury; with special reference to the mechanisms involved in hyperextension injuries of cervical spine. J. Neurosurg. 11, 546-577 (1954).
86. Fehlings, M. G. et al. The aging of the global population: the changing epidemiology of disease and spinal disorders. Neurosurgery 77, S1-S5 (2015).
87. McKinley, W., Santos, K., Meade, M. & Brooke, K. Incidence and outcomes of spinal cord injury clinical syndromes. J. Spinal Cord Med. 30, 215-224 (2007).
88. Burns, A. & Ditunno, J. Establishing prognosis and maximizing functional outcomes after spinal cord injury. Spine 26, S137-S145 (2001).
89. Kirshblum, S., Millis, S., McKinley, W. & Tulsky, D. Late neurologic recovery after traumatic spinal cord injury. Arch. Phys. Med. Rehabil. 85, 1811-1817 (2004).
90. Fawcett, J. et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic trials. Spinal Cord 45, 190-205 (2007).
91. Marino, R., Dittuno, J., Donovan, W. & Maynard, F. Neurologic recovery after traumatic spinal cord injury: data from the model spinal cord injury systems. Arch. Phys. Med. Rehabil. 80, 1391-1396 (1999).
92. Waters, R., Yakura, J., Adkins, R. & Sie, I. Recovery following complete paraplegia. Arch. Phys. Med. Rehabil. 73, 784-789 (1992).
93. Coleman, W. & Geisler, F. Injury severity as primary predictor of outcome in acute spinal cord injury: retrospective results from a large multicenter clinical trial. Spine J. 4, 373-378 (2004).
94. Kay, E., Deutsch, A. & Wuermser, L. Predicting walking at discharge from inpatient rehabilitation after a traumatic spinal cord injury. Arch. Phys. Med. Rehabil. 88, 745-750 (2007).
95. van Middendorp, J. J. et al. A clinical prediction rule for ambulation outcomes after traumatic spinal cord injury: a longitudinal cohort study. Lancet 377, 1004-1010 (2011).
96. Wilson, J. R. et al. A clinical prediction model for long-term functional outcome after traumatic spinal cord injury based on acute clinical and imaging factors. J. Neurotrauma 29, 2263-2271 (2012).
97. Pavese, C. et al. Prediction of bladder outcomes after traumatic spinal cord injury: a longitudinal cohort study. PLoS Med. 13, e1002041 (2016).
98. Ryken, T. C. et al. The acute cardiopulmonary management of patients with cervical spinal cord injuries. Neurosurgery 72 (Suppl. 2), 84-92 (2013).
99. Braughler, J. & Hall, E. Effects of multi-dose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degradation and energy metabolism. J. Neurosurg. 61, 290-295 (1984).
100. Hall, E. D. & Braughler, J. M. Glucocorticoid mechanisms in acute spinal cord injury: a review and therapeutic rationale. Surg. Neurol. 18, 320-327 (1982).
101. Hall, E. D. & Braughler, J. M. Effects of intravenous methylprednisolone on spinal cord lipid peroxidation and Na+ + K+)-ATPase activity. Dose-response analysis during 1st hour after contusion injury in the cat. J. Neurosurg. 57, 247-253 (1982).
102. Bracken, M. et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 277, 1597-1604 (1997).
103. Bracken, M. B. et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N. Engl. J. Med. 322, 1405-1411 (1990).
104. Bracken, M. B. et al. Efficacy of methylprednisolone in acute spinal cord injury. JAMA 251, 45-52 (1984).
105. Bracken, M. B. Steroids for acute spinal cord injury. Cochrane Database Syst. Rev. 18, CD001046 (2012).
106. Eck, J. C., Nachtigall, D., Humphreys, S. C. & Hodges, S. D. Questionnaire survey of spine surgeons on the use of methylprednisolone for acute spinal cord injury. Spine 31, E250-E253 (2006).
107. Hurlbert, R. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J. Neurosurg. Spine 93, 1-7 (2000).
108. Hurlbert, R. J. et al. Pharmacological therapy for acute spinal cord injury. Neurosurgery 72 (Suppl. 2), 93-105 (2013).
109. Hadley, M. et al. Pharmacological therapy after acute cervical spinal cord injury. Neurosurgery 50, 563-572 (2002).
110. Fehlings, M. G., Wilson, J. R. & Cho, N. Methylprednisolone for the treatment of acute spinal cord injury: counterpoint. Neurosurgery 61 (Suppl. 1), 36-42 (2014).
111. Hurlbert, R. J. Methylprednisolone for the treatment of acute spinal cord injury: point. Neurosurgery 61 (Suppl. 1), 32-35 (2014).
112. Carlson, G. D. et al. Early time-dependent decompression for spinal cord injury: vascular mechanisms of recovery. J. Neurotrauma 14, 951-962 (1997).
113. Dimar, J., Glassman, S., Raque, G., Zhang, Y. & Shields, C. The influence of spinal canal narrowing and timing of decompression on neurologic recovery after spinal cord contusion in a rat model. Spine 24, 1623-1633 (1999).
114. Batchelor, P. E. et al. Meta-analysis of pre-clinical studies of early decompression in acute spinal cord injury: a battle of time and pressure. PLoS ONE 8, e72659 (2013).
115. Wilson, J. R. et al. Early versus late surgery for traumatic spinal cord injury: the results of a prospective Canadian cohort study. Spinal Cord 50, 840-843 (2012).
116. Bourassa-Moreau, E., Mac-Thiong, J. M., Feldman, D. E., Thompson, C. & Parent, S. Non-neurological outcomes after complete traumatic spinal cord injury: the impact of surgical timing. J. Neurotrauma 30, 1596-1601 (2013).
117. Grassner, L. et al. Early decompression (8 h) after traumatic cervical spinal cord injury improves functional outcome as assessed by spinal cord independence measure after one year. J. Neurotrauma 33, 1658-1666 (2016).
118. Fehlings, M., Rabin, D., Sears, W., Cadotte, D. & Aarabi, B. Current practice in the timing of surgical intervention in spinal cord injury. Spine 35, 166-173 (2010).
119. Brodbelt, A. R. & Stoodley, M. A. Post-traumatic syringomyelia: a review. J. Clin. Neurosci. 10, 401-408 (2003).
120. Schurch, B., Wichmann, W. & Rossier, A. B. Post-traumatic syringomyelia (cystic myelopathy): a prospective study of 449 patients with spinal cord injury. J. Neurol. Neurosurg. Psychiatry 60, 61-67 (1996).
121. Alpert, S. W., Koval, K. J. & Zuckerman, J. D. Neuropathic arthropathy: review of current knowledge. J. Am. Acad. Orthop. Surg. 4, 100-108 (1996).
122. Aebli, N., Potzel, T. & Krebs, J. Characteristics and surgical management of neuropathic (Charcot) spinal arthropathy after spinal cord injury. Spine J. 14, 884-891 (2014).
123. Adams, M. M. & Hicks, A. L. Spasticity after spinal cord injury. Spinal Cord 43, 577-586 (2005).
124. Sezer, N., Akkus, S. & Ugurlu, F. G. Chronic complications of spinal cord injury. World J. Orthop. 6, 24-33 (2015).
125. Claydon, V. E., Steeves, J. D. & Krassioukov, A. Orthostatic hypotension following spinal cord injury: understanding clinical pathophysiology. Spinal Cord 44, 341-351 (2006).
126. Krassioukov, A., Eng, J. J., Warburton, D. E., Teasell, R. & Spinal Cord Injury Rehabilitation Evidence Research Team. A systematic review of the management of orthostatic hypotension after spinal cord injury. Arch. Phys. Med. Rehabil. 90, 876-885 (2009).
127. Krassioukov, A., Warburton, D. E., Teasell, R. & Eng, J. J. A systematic review of the management of autonomic dysreflexia after spinal cord injury. Arch. Phys. Med. Rehabil. 90, 682-695 (2009).
128. Blackmer, J. Rehabilitation medicine: 1. Autonomic dysreflexia. CMAJ 169, 931-935 (2003).
129. Linn, W. S., Adkins, R. H., Gong, H. Jr & Waters, R. L. Pulmonary function in chronic spinal cord injury: a cross-sectional survey of 222 southern California adult outpatients. Arch. Phys. Med. Rehabil. 81, 757-763 (2000).
130. Brown, R., DiMarco, A. F., Hoit, J. D. & Garshick, E. Respiratory dysfunction and management in spinal cord injury. Respir. Care 51, 853-868 (2006).
131. Winslow, C. & Rozovsky, J. Effect of spinal cord injury on the respiratory system. Am. J. Phys. Med. Rehabil. 82, 803-814 (2003).
132. DeVivo, M. J., Black, K. J. & Stover, S. L. Causes of death during the first 12 years after spinal cord injury. Arch. Phys. Med. Rehabil. 74, 248-254 (1993).
133. Brommer, B. et al. Spinal cord injury-induced immune deficiency syndrome enhances infection susceptibility dependent on lesion level. Brain 139, 692-707 (2016).
134. Ulndreaj, A., Chio, J. C., Ahuja, C. S. & Fehlings, M. G. Modulating the immune response in spinal cord injury. Expert Rev. Neurother. 16, 1127-1129 (2016).
135. Benevento, B. T. & Sipski, M. L. Neurogenic bladder, neurogenic bowel, and sexual dysfunction in people with spinal cord injury. Phys. Ther. 82, 601-612 (2002).
136. Taweel, W. A. & Seyam, R. Neurogenic bladder in spinal cord injury patients. Res. Rep. Urol. 7, 85-99 (2015).
137. Hess, M. J. & Hough, S. Impact of spinal cord injury on sexuality: broad-based clinical practice intervention and practical application. J. Spinal Cord Med. 35, 211-218 (2012).
138. Coggrave, M. J. & Norton, C. The need for manual evacuation and oral laxatives in the management of neurogenic bowel dysfunction after spinal cord injury: a randomized controlled trial of a stepwise protocol. Spinal Cord 48, 504-510 (2010).
139. Krassioukov, A., Eng, J. J., Claxton, G., Sakakibara, B. M. & Shum, S. Neurogenic bowel management after spinal cord injury: a systematic review of the evidence. Spinal Cord 48, 718-733 (2010).
140. Consortium for Spinal Cord Medicine Clinical Practice Guidelines. Pressure ulcer prevention and treatment following spinal cord injury: a clinical practice guideline for health-care professionals. J. Spinal Cord Med. 24, S40-S101 (2001).
141. van Kuijk, A. A., Geurts, A. C. & van Kuppevelt, H. J. Neurogenic heterotopic ossification in spinal cord injury. Spinal Cord 40, 313-326 (2002).
142. Rush, P. J. The rheumatic manifestations of traumatic spinal cord injury. Semin. Arthritis Rheum. 19, 77-89 (1989).
143. Cardenas, D. D. & Felix, E. R. Pain after spinal cord injury: a review of classification, treatment approaches, and treatment assessment. PM R 1, 1077-1090 (2009).
144. Gomara-Toldra, N., Sliwinski, M. & Dijkers, M. P. Physical therapy after spinal cord injury: a systematic review of treatments focused on participation. J. Spinal Cord Med. 37, 371-379 (2014).
145. Hwang, D. H. et al. Survival of neural stem cell grafts in the lesioned spinal cord is enhanced by a combination of treadmill locomotor training via insulin-like growth factor-1 signaling. J. Neurosci. 34, 12788-12800 (2014).
146. Dobkin, B. et al. Weight-supported treadmill versus over-ground training for walking after acute incomplete SCI. Neurology 66, 484-493 (2006).
147. Stiens, S. A., Kirshblum, S. C., Groah, S. L., McKinley, W. O. & Gittler, M. S. Spinal cord injury medicine. 4. Optimal participation in life after spinal cord injury: physical, psychosocial, and economic reintegration into the environment. Arch. Phys. Med. Rehabil. 83, S72-S81 (2002).
148. Ho, C. H. et al. Functional electrical stimulation and spinal cord injury. Phys. Med. Rehabil. Clin. N. Am. 25, 631-654 (2014).
149. Bhambhani, Y., Tuchak, C., Burnham, R., Jeon, J. & Maikala, R. Quadriceps muscle deoxygenation during functional electrical stimulation in adults with spinal cord injury. Spinal Cord 38, 630-638 (2000).
150. Kakebeeke, T. H. et al. Training and detraining of a tetraplegic subject: high-volume FES cycle training. Am. J. Phys. Med. Rehabil. 87, 56-64 (2008).
151. Ragnarsson, K. T. Functional electrical stimulation after spinal cord injury: current use, therapeutic effects and future directions. Spinal Cord 46, 255-274 (2008).
152. Tate, D. & Forchheimer, M. Review of cross-cultural issues related to quality of life after spinal cord injury. Top. Spinal Cord Inj. Rehabil. 20, 181-190 (2014).
153. Wilson, J. R., Hashimoto, R. E., Dettori, J. R. & Fehlings, M. G. Spinal cord injury and quality of life: a systematic review of outcome measures. Evid. Based Spine Care J. 2, 37-44 (2011).
154. Tulsky, D. S. et al. Overview of the Spinal Cord Injury-Quality of Life (SCI-QOL) measurement system. J. Spinal Cord Med. 38, 257-269 (2015).
155. Dijkers, M. Quality of life after spinal cord injury: a meta analysis of the effects of disablement components. Spinal Cord 35, 829-840 (1997).
156. Clayton, K. S. & Chubon, R. A. Factors associated with the quality of life of long-term spinal cord injured persons. Arch. Phys. Med. Rehabil. 75, 633-638 (1994).
157. Evans, R. L. et al. Quality of life after spinal cord injury: a literature critique and meta-analysis (1983-1992). J. Am. Paraplegia Soc. 17, 60-66 (1994).
158. Fuhrer, M. J., Rintala, D. H., Hart, K. A., Clearman, R. & Young, M. E. Relationship of life satisfaction to impairment, disability, and handicap among persons with spinal cord injury living in the community. Arch. Phys. Med. Rehabil. 73, 552-557 (1992).
159. Gerhart, K. A., Koziol-McLain, J., Lowenstein, S. R. & Whiteneck, G. G. Quality of life following spinal cord injury: knowledge and attitudes of emergency care providers. Ann. Emerg. Med. 23, 807-812 (1994).
160. Krause, J. S. & Crewe, N. M. Chronologic age, time since injury, and time of measurement: effect on adjustment after spinal cord injury. Arch. Phys. Med. Rehabil. 72, 91-100 (1991).
161. Jain, N. B., Sullivan, M., Kazis, L. E., Tun, C. G. & Garshick, E. Factors associated with health-related quality of life in chronic spinal cord injury. Am. J. Phys. Med. Rehabil. 86, 387-396 (2007).
162. Brillhart, B. & Johnson, K. Motivation and the coping process of adults with disabilities: a qualitative study. Rehabil. Nurs. 22, 249-256 (1997).
163. Siosteen, A., Lundqvist, C., Blomstrand, C., Sullivan, L. & Sullivan, M. The quality of life of three functional spinal cord injury subgroups in a Swedish community. Paraplegia 28, 476-488 (1990).
164. DeVivo, M. J. & Richards, J. S. Community reintegration and quality of life following spinal cord injury. Paraplegia 30, 108-112 (1992).
165. Saadat, S. et al. Health-related quality of life among individuals with long-standing spinal cord injury: a comparative study of veterans and non-veterans. BMC Public Health 10, 6 (2010).
166. Westgren, N. & Levi, R. Quality of life and traumatic spinal cord injury. Arch. Phys. Med. Rehabil. 79, 1433-1439 (1998).
167. Bracken, M. B. et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 277, 1597-1604 (1997).
168. Kwon, B. K. et al. Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury. J. Neurotrauma 27, 669-682 (2010).
169. Siddiqui, A. M., Khazaei, M. & Fehlings, M. G. Translating mechanisms of neuroprotection, regeneration, and repair to treatment of spinal cord injury. Prog. Brain Res. 218, 15-54 (2015).
170. Grossman, R. G., Toups, E. G., Frankowski, R. F., Burau, K. D. & Howley, S. North American Clinical Trials Network for the Treatment of Spinal Cord Injury: goals and progress. J. Neurosurg. Spine 17 (1 Suppl.), 6-10 (2012).
171. DeVivo, M. et al. International spinal cord injury core data set. Spinal Cord 44, 535-540 (2006).
172. DeVivo, M. J., Go, B. K. & Jackson, A. B. Overview of the national spinal cord injury statistical center database. J. Spinal Cord Med. 25, 335-338 (2002).
173. Ahuja, C. S. & Fehlings, M. Concise review: bridging the gap: novel neuroregenerative and neuroprotective strategies in spinal cord injury. Stem Cells Transl Med. 5, 914-924 (2016).
174. Wells, J., Hurlbert, R., Fehlings, M. & Yong, V. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 126, 1628-1637 (2003).
175. Lee, S. M. et al. Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J. Neurotrauma 20, 1017-1027 (2003).
176. Wilson, J. R. & Fehlings, M. G. Riluzole for acute traumatic spinal cord injury: a promising neuroprotective treatment strategy. World Neurosurg. 81, 825-829 (2013).
177. Grossman, R. G. et al. A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury. J. Neurotrauma 31, 239-255 (2014).
178. Santa-Olalla, J. & Covarrubias, L. Basic fibroblast growth factor promotes epidermal growth factor responsiveness and survival of mesencephalic neural precursor cells. J. Neurobiol. 40, 14-27 (1999).
179. Teng, Y. D., Mocchetti, I., Taveira-DaSilva, A. M., Gillis, R. A. & Wrathall, J. R. Basic fibroblast growth factor increases long-term survival of spinal motor neurons and improves respiratory function after experimental spinal cord injury. J. Neurosci. 19, 7037-7047 (1999).
180. Rabchevsky, A. G. et al. Basic fibroblast growth factor (bFGF) enhances functional recovery following severe spinal cord injury to the rat. Exp. Neurol. 164, 280-291 (2000).
181. Batchelor, P. E. et al. Hypothermia prior to decompression: buying time for treatment of acute spinal cord injury. J. Neurotrauma 27, 1357-1368 (2010).
182. Levi, A. D. et al. Clinical outcomes using modest intravascular hypothermia after acute cervical spinal cord injury. Neurosurgery 66, 670-677 (2010).
183. Dergham, P., Ellezam, B. & Essagian, C. Rho signalling pathway targeted to promote spinal cord repair. J. Neurosci. 22, 6570-6577 (2002).
184. Kwon, B. K., Sekhon, L. H. & Fehlings, M. G. Emerging repair, regeneration, and translational research advances for spinal cord injury. Spine 35, S263-S270 (2010).
185. Fehlings, M. G. et al. A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury. J. Neurotrauma 28, 787-796 (2011).
186. Freund, P. et al. Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey. J. Comp. Neurol. 502, 644-659 (2007).
187. Zorner, B. & Schwab, M. E. Anti-Nogo on the go: from animal models to a clinical trial. Ann. NY Acad. Sci. 1198 (Suppl. 1), E22-E34 (2010).
188. Harrop, J. S. et al. Evaluation of clinical experience using cell-based therapies in patients with spinal cord injury: a systematic review. J. Neurosurg. Spine 17, 230-246 (2012).
189. Tetzlaff, W. et al. A systematic review of cellular transplantation therapies for spinal cord injury. J. Neurotrauma 28, 1611-1682 (2011).
190. Khazaei, M., Ahuja, C. S. & Fehlings, M. G. Induced pluripotent stem cells for traumatic spinal cord injury. Front. Cell Dev. Biol. 4, 152 (2017).
191. Ramon-Cueto, A., Cordero, M. I., Santos-Benito, F. F. & Avila, J. Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron 25, 425-435 (2000).
192. Keyvan-Fouladi, N., Raisman, G. & Li, Y. Functional repair of the corticospinal tract by delayed transplantation of olfactory ensheathing cells in adult rats. J. Neurosci. 23, 9428-9434 (2003).
193. Pascual, J. I., Gudino-Cabrera, G., Insausti, R. & Nieto-Sampedro, M. Spinal implants of olfactory ensheathing cells promote axon regeneration and bladder activity after bilateral lumbosacral dorsal rhizotomy in the adult rat. J. Urol. 167, 1522-1526 (2002).
194. Li, Y., Decherchi, P. & Raisman, G. Transplantation of olfactory ensheathing cells into spinal cord lesions restores breathing and climbing. J. Neurosci. 23, 727-731 (2003).
195. Boyd, J. G., Lee, J., Skihar, V., Doucette, R. & Kawaja, M. D. LacZ-expressing olfactory ensheathing cells do not associate with myelinated axons after implantation into the compressed spinal cord. Proc. Natl Acad. Sci. USA 101, 2162-2166 (2004).
196. Li, J. & Lepski, G. Cell transplantation for spinal cord injury: a systematic review. Biomed. Res. Int. 2013, 786475 (2013).
197. Pastrana, E. et al. Genes associated with adult axon regeneration promoted by olfactory ensheathing cells: a new role for matrix metalloproteinase 2. J. Neurosci. 26, 5347-5359 (2006).
198. Guo, J. S. et al. Cotransplant of neural stem cells and NT-3 gene modified Schwann cells promote the recovery of transected spinal cord injury. Spinal Cord 45, 15-24 (2007).
199. Mackay-Sim, A. et al. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain 131, 2376-2386 (2008).
200. Dlouhy, B. J., Awe, O., Rao, R. C., Kirby, P. A. & Hitchon, P. W. Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient: case report. J. Neurosurg. Spine 21, 618-622 (2014).
201. Chhabra, H. S. et al. Autologous olfactory [corrected] mucosal transplant in chronic spinal cord injury: an Indian pilot study. Spinal Cord 47, 887-895 (2009).
202. Tabakow, P. et al. Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury. Cell Transplant. 22, 1591-1612 (2013).
203. Hill, C. E., Moon, L. D., Wood, P. M. & Bunge, M. B. Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival. Glia 53, 338-343 (2006).
204. Li, L. et al. Effects of transplantation of olfactory ensheathing cells in chronic spinal cord injury: a systematic review and meta-analysis. Eur. Spine J. 24, 919-930 (2015).
205. Zhu, H. et al. Phase I-II clinical trial assessing safety and efficacy of umbilical cord blood mononuclear cell transplant therapy of chronic complete spinal cord injury. Cell Transplant. 25, 1925-1943 (2016).
206. Harkema, S. et al. Effect of epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study. Lancet 377, 1938-1947 (2011).
207. Bachmann, L. C. et al. Deep brain stimulation of the midbrain locomotor region improves paretic hindlimb function after spinal cord injury in rats. Sci. Transl Med. 5, 208ra146 (2013).
208. Bouton, C. E. et al. Restoring cortical control of functional movement in a human with quadriplegia. Nature 533, 247-250 (2016).
209. Zeilig, G. et al. Safety and tolerance of the ReWalk exoskeleton suit for ambulation by people with complete spinal cord injury: a pilot study. J. Spinal Cord Med. 35, 96-101 (2012).
210. Miller, L. E., Zimmermann, A. K. & Herbert, W. G. Clinical effectiveness and safety of powered exoskeleton-assisted walking in patients with spinal cord injury: systematic review with meta-analysis. Med. Devices (Auckl.) 9, 455-466 (2016).
211. Akhtar, A. Z., Pippin, J. J. & Sandusky, C. B. Animal models in spinal cord injury: a review. Rev. Neurosci. 19, 47-60 (2008).
212. Basso, D. M. Behavioral testing after spinal cord injury: congruities, complexities, and controversies. J. Neurotrauma 21, 395-404 (2004).
213. Kwon, B. K., Oxland, T. R. & Tetzlaff, W. Animal models used in spinal cord regeneration research. Spine 27, 1504-1510 (2002).
214. Calancie, B., Molano, M. R. & Broton, J. G. EMG for assessing the recovery of voluntary movement after acute spinal cord injury in man. Clin. Neurophysiol. 115, 1748-1759 (2004).
215. Curt, A. & Dietz, V. Nerve conduction study in cervical spinal cord injury: significance for hand function. NeuroRehabilitation 7, 165-173 (1996).
216. Jacobs, S. R., Yeaney, N. K., Herbison, G. J. & Ditunno, J. F. Jr. Future ambulation prognosis as predicted by somatosensory evoked potentials in motor complete and incomplete quadriplegia. Arch. Phys. Med. Rehabil. 76, 635-641 (1995).
217. Ogura, T. et al. Sympathetic skin response in patients with spinal cord injury. J. Orthop. Surg. (Hong Kong) 12, 35-39 (2004).
218. Bradbury, E. J. & McMahon, S. B. Spinal cord repair strategies: why do they work Nat. Rev. Neurosci. 7, 644-653 (2006).
219. Takahashi, H. et al. Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I/IIa clinical trial. Eur. Spine J. 21, 2580-2587 (2012).
220. Kamiya, K. et al. Neuroprotective therapy with granulocyte colony-stimulating factor in acute spinal cord injury: a comparison with high-dose methylprednisolone as a historical control. Eur. Spine J. 24, 963-967 (2015).
221. Lo, T. P. Jr et al. Systemic hypothermia improves histological and functional outcome after cervical spinal cord contusion in rats. J. Comp. Neurol. 514, 433-448 (2009).
222. Levi, A. D. et al. Clinical application of modest hypothermia after spinal cord injury. J. Neurotrauma 26, 407-415 (2009).